FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3157887579> ?p ?o ?g. }

• W3157887579 abstract "Macroprolactinomas are rarely seen in women, and pregnancy is a risk factor for tumor growth. More studies are needed to determine appropriate management for macroprolactinoma and pregnancy. The aim of our study is to evaluate effects of treatment with dopamine agonists on macroadenoma before and during pregnancy, safety of dopamine agonists on fetus, post-pregnancy prognosis and long-term results. This is a single center retrospective study. Thirty-four pregnancies occurred in 21 patients under medical therapy. Prolactin levels, treatment results, tumor diameter changes, maternal-fetal outcomes, and disease activity were evaluated. The median tumor size at the time of diagnosis was 15 mm (10-28). Residual adenoma diameter was smaller in those receiving medical therapy longer than one year till the conception (p=0.047). Treatment was discontinued in 28 pregnancies after pregnancy confirmation, and 6 patients were exposed to bromocriptine throughout pregnancy. There was no symptomatic tumor growth during gestation. Among 27 live births, none of the fetuses developed neonatal malformation except for a case of Down syndrome. While early remission rate after pregnancy was 9.5%, this rate reached 33.3% at last follow-up visit. Lowered PRL levels at postpartum period (p=0.040), smaller tumor size at last follow-up visit (p=0.030), and total disappearance of tumor (p=0.026) were the contributor factors for remission. Use of dopamine agonist over one year may reduce the risk of symptomatic tumor growth during pregnancy in patients without invasive or large macroprolactinoma before pregnancy. Exposure to dopamine agonists seems generally safe for the fetus.Macroprolactinomas are rarely seen in women, and pregnancy is a risk factor for tumor growth. More studies are needed to determine appropriate management for macroprolactinoma and pregnancy. The aim of our study is to evaluate effects of treatment with dopamine agonists on macroadenoma before and during pregnancy, safety of dopamine agonists on fetus, post-pregnancy prognosis and long-term results. This is a single center retrospective study. Thirty-four pregnancies occurred in 21 patients under medical therapy. Prolactin levels, treatment results, tumor diameter changes, maternal-fetal outcomes, and disease activity were evaluated. The median tumor size at the time of diagnosis was 15 mm (10–28). Residual adenoma diameter was smaller in those receiving medical therapy longer than one year till the conception (p=0.047). Treatment was discontinued in 28 pregnancies after pregnancy confirmation, and 6 patients were exposed to bromocriptine throughout pregnancy. There was no symptomatic tumor growth during gestation. Among 27 live births, none of the fetuses developed neonatal malformation except for a case of Down syndrome. While early remission rate after pregnancy was 9.5%, this rate reached 33.3% at last follow-up visit. Lowered PRL levels at postpartum period (p=0.040), smaller tumor size at last follow-up visit (p=0.030), and total disappearance of tumor (p=0.026) were the contributor factors for remission. Use of dopamine agonist over one year may reduce the risk of symptomatic tumor growth during pregnancy in patients without invasive or large macroprolactinoma before pregnancy. Exposure to dopamine agonists seems generally safe for the fetus." @default.
• W3157887579 created "2021-05-10" @default.
• W3157887579 creator A5059102053 @default.
• W3157887579 creator A5075615482 @default.
• W3157887579 date "2021-04-26" @default.
• W3157887579 modified "2023-10-16" @default.
• W3157887579 title "Outcomes of Patients with Macroprolactinoma Desiring Pregnancy: Follow-Up to 23 Years from a Single Center" @default.
• W3157887579 cites W1549927454 @default.
• W3157887579 cites W1990061063 @default.
• W3157887579 cites W1992388781 @default.
• W3157887579 cites W1998889883 @default.
• W3157887579 cites W2004096655 @default.
• W3157887579 cites W2011863772 @default.
• W3157887579 cites W2017283375 @default.
• W3157887579 cites W2019055295 @default.
• W3157887579 cites W2034141789 @default.
• W3157887579 cites W2047245583 @default.
• W3157887579 cites W2050434570 @default.
• W3157887579 cites W2081270402 @default.
• W3157887579 cites W2090398112 @default.
• W3157887579 cites W2103238322 @default.
• W3157887579 cites W2116305496 @default.
• W3157887579 cites W2160101410 @default.
• W3157887579 cites W2213483244 @default.
• W3157887579 cites W2415014613 @default.
• W3157887579 cites W2557733567 @default.
• W3157887579 cites W2620327112 @default.
• W3157887579 cites W2653912184 @default.
• W3157887579 cites W2782602987 @default.
• W3157887579 cites W2946684031 @default.
• W3157887579 cites W2951586096 @default.
• W3157887579 cites W2978339214 @default.
• W3157887579 cites W2987128550 @default.
• W3157887579 cites W2992409972 @default.
• W3157887579 cites W3001017553 @default.
• W3157887579 doi "https://doi.org/10.1055/a-1468-4608" @default.
• W3157887579 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33902136" @default.
• W3157887579 hasPublicationYear "2021" @default.
• W3157887579 type Work @default.
• W3157887579 sameAs 3157887579 @default.
• W3157887579 citedByCount "1" @default.
• W3157887579 countsByYear W31578875792022 @default.
• W3157887579 crossrefType "journal-article" @default.
• W3157887579 hasAuthorship W3157887579A5059102053 @default.
• W3157887579 hasAuthorship W3157887579A5075615482 @default.
• W3157887579 hasBestOaLocation W31578875791 @default.
• W3157887579 hasConcept C126322002 @default.
• W3157887579 hasConcept C131872663 @default.
• W3157887579 hasConcept C137183658 @default.
• W3157887579 hasConcept C167135981 @default.
• W3157887579 hasConcept C172680121 @default.
• W3157887579 hasConcept C2776856834 @default.
• W3157887579 hasConcept C2778258207 @default.
• W3157887579 hasConcept C2778918492 @default.
• W3157887579 hasConcept C2779064019 @default.
• W3157887579 hasConcept C2779234561 @default.
• W3157887579 hasConcept C2781449511 @default.
• W3157887579 hasConcept C29456083 @default.
• W3157887579 hasConcept C46973012 @default.
• W3157887579 hasConcept C513476851 @default.
• W3157887579 hasConcept C54355233 @default.
• W3157887579 hasConcept C71315377 @default.
• W3157887579 hasConcept C71924100 @default.
• W3157887579 hasConcept C86803240 @default.
• W3157887579 hasConceptScore W3157887579C126322002 @default.
• W3157887579 hasConceptScore W3157887579C131872663 @default.
• W3157887579 hasConceptScore W3157887579C137183658 @default.
• W3157887579 hasConceptScore W3157887579C167135981 @default.
• W3157887579 hasConceptScore W3157887579C172680121 @default.
• W3157887579 hasConceptScore W3157887579C2776856834 @default.
• W3157887579 hasConceptScore W3157887579C2778258207 @default.
• W3157887579 hasConceptScore W3157887579C2778918492 @default.
• W3157887579 hasConceptScore W3157887579C2779064019 @default.
• W3157887579 hasConceptScore W3157887579C2779234561 @default.
• W3157887579 hasConceptScore W3157887579C2781449511 @default.
• W3157887579 hasConceptScore W3157887579C29456083 @default.
• W3157887579 hasConceptScore W3157887579C46973012 @default.
• W3157887579 hasConceptScore W3157887579C513476851 @default.
• W3157887579 hasConceptScore W3157887579C54355233 @default.
• W3157887579 hasConceptScore W3157887579C71315377 @default.
• W3157887579 hasConceptScore W3157887579C71924100 @default.
• W3157887579 hasConceptScore W3157887579C86803240 @default.
• W3157887579 hasLocation W31578875791 @default.
• W3157887579 hasLocation W31578875792 @default.
• W3157887579 hasOpenAccess W3157887579 @default.
• W3157887579 hasPrimaryLocation W31578875791 @default.
• W3157887579 hasRelatedWork W12335207 @default.
• W3157887579 hasRelatedWork W13321621 @default.
• W3157887579 hasRelatedWork W13871421 @default.
• W3157887579 hasRelatedWork W1424066 @default.
• W3157887579 hasRelatedWork W15594581 @default.
• W3157887579 hasRelatedWork W15842497 @default.
• W3157887579 hasRelatedWork W17260313 @default.
• W3157887579 hasRelatedWork W3473159 @default.
• W3157887579 hasRelatedWork W6935370 @default.
• W3157887579 hasRelatedWork W8370635 @default.
• W3157887579 isParatext "false" @default.
• W3157887579 isRetracted "false" @default.
• W3157887579 magId "3157887579" @default.
• W3157887579 workType "article" @default.